PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Dealmaking in 2017: Striking a Balance

Gottlieb Tackles FDA’s Reputation Problem

Controversial 340B Drug Discounts Linked to Drug Pricing Issues

Value
The Man with a Price: ICER Founder Steven Pearson
Everyone’s talking value, but not everyone is willing to pin down the elusive concept. Steven Pearson, founder of the Boston-based, not-for-profit Institute for Clinical Effectiveness Review (ICER) talks all things value-based with Pharm Exec
/Read more/
Advertisement
Using Outbound Virtual Engagement Strategies to Break Through Co-Pay Savings Program Plateaus
Sponsored by TrialCard
Download Whitepaper
Value
Value Creation Powered by Data
In the first of a series on how digital strategy and a “data culture” can help define and deliver value, David Ormesher focuses on Value Creation
/Read more/
Advertisement
The Changing Market for Drugs to Treat Orphan Diseases
On Demand
Learn more
Washington Report
Pressure Mounts on FDA, Pharma to Tackle Opioid Abuse
The growing toll requires new assessment of risks, expanded provider education, and more scrutiny of marketed products. Jill Wechsler reports
/Read more/
Advertisement
Through the Patient's Eyes - Needs, Behaviors and the Science Behind it All
On Demand
Learn more
Interview
IFPMA’s Fumie Griego: Health Policy Problem Solver
The International Federation of Pharmaceutical Manufacturers and Associations’ new Assistant Director General, Dr. Fumie Griego, speaks about her mission to use IFPMA ’s international reach to find real and practical solutions to the most pressing global healthcare challenges
/Read more/
Special Feature
Pharma in the News Spotlight
With media coverage of pharma the highest in a decade, Pharm Exec’s latest annual press audit reveals a tonal undercurrent in sync with an industry unable to escape the glare of scrutiny while navigating its own operational challenges
/Read more/
Advertisement
15th Annual Global Forum
Sept 25-29, 2017
Hyatt Regency McCormick Place, Chicago, IL

Returning for its 15th iteration, the world’s largest event for temperature-controlled life science supply chains heads back to Chicago this year with a focus on the next generation of temperature control! Join 850+ attendees from 30+ countries for five days of master classes, workshops, track sessions, panel discussions, roundtables, and more. With the Global Forum, your company will meet emerging and ongoing challenges for 2017 and beyond.
Register now
Calendar
/ September 11–12: Bio/Pharma Product Launch Summit /
Boston, MA
/ September 14-15, 2017: Compliance Congress for Specialty Products /
Boston, MA
/ September 14–15: Risk Based Global Monitoring 2017 /
Barcelona, Spain
/ September 27–28: Finance and Accounting for Bioscience Companies /
New Brinswick, NJ
/ October 24–25: 12th Annual Value-Based Oncology Management /
Scottsdale, AZ
/ February 27–28, 2018: Speaker Programs 2018 /
Philadelphia, PA
Industry update
//Novo Nordisk (Bagsværd, Denmark) announced that, as of October 1, Camilla Sylvest, Senior Vice President in charge of Novo’s operations in Region China, will become Executive Vice President in charge of Commercial Strategy & Corporate Affairs. Novo’s Senior Vice President, Head of North America Operations and President of Novo Nordisk Inc, Doug Langa, was also promoted to Executive Vice President. His responsibilities remain unchanged. //Turnstone Biologics (Ottawa, Ontario and New York, NY) appointed Kris Elverum as Chief Business Officer and Dr. José Manuel Otero as Vice President, Manufacturing And CMC (chemistry, manufacturing and controls). //Michael H. Davidson, M.D. joined the International Board of Medical Affairs Officers with the Accreditation Council for Medical Affairs (New York, NY). //PharmaCord (Louisville, KY) named Cindy Padgett as Vice President of Commercial Operations. //
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com